XYLO TECHNOLOGIES LTD (XYLO) Stock Price & Overview
NASDAQ:XYLO • US58471G5080
Current stock price
The current stock price of XYLO is 5.07 USD. Today XYLO is down by 0%. In the past month the price decreased by -0.98%. In the past year, price increased by 40.44%.
XYLO Key Statistics
- Market Cap
- 9.606M
- P/E
- N/A
- Fwd P/E
- 0.79
- EPS (TTM)
- -3.46
- Dividend Yield
- N/A
XYLO Stock Performance
XYLO Stock Chart
XYLO Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to XYLO. When comparing the yearly performance of all stocks, XYLO is one of the better performing stocks in the market, outperforming 78.82% of all stocks.
XYLO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to XYLO. XYLO has a bad profitability rating. Also its financial health evaluation is rather negative.
XYLO Earnings
XYLO Forecast & Estimates
For the next year, analysts expect an EPS growth of 1216.67% and a revenue growth 5.71% for XYLO
XYLO Groups
Sector & Classification
XYLO Financial Highlights
Over the last trailing twelve months XYLO reported a non-GAAP Earnings per Share(EPS) of -3.46. The EPS increased by 66.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -16.05% | ||
| ROE | -33.51% | ||
| Debt/Equity | 0.07 |
XYLO Ownership
XYLO Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 41.05 | 170.062B | ||
| ABT | ABBOTT LABORATORIES | 14.72 | 160.7B | ||
| SYK | STRYKER CORP | 21.8 | 126.249B | ||
| BSX | BOSTON SCIENTIFIC CORP | 16.64 | 97.627B | ||
| EW | EDWARDS LIFESCIENCES CORP | 23.63 | 45.962B | ||
| IDXX | IDEXX LABORATORIES INC | 37.88 | 44.549B | ||
| BDX | BECTON DICKINSON AND CO | 11.35 | 44.092B | ||
| RMD | RESMED INC | 17.88 | 31.978B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.52 | 31.89B | ||
| DXCM | DEXCOM INC | 24.65 | 24.131B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.9 | 17.894B | ||
| PODD | INSULET CORP | 29.65 | 13.313B | ||
| PEN | PENUMBRA INC | 65.33 | 13.094B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About XYLO
Company Profile
Xylo Technologies Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm developed a range of micro video cameras under micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD).
Company Info
IPO: 2006-02-27
XYLO TECHNOLOGIES LTD
7A Industrial Park,, P.O. Box 3030
OMER IL
Employees: 38
Phone: 97286466880
XYLO TECHNOLOGIES LTD / XYLO FAQ
What does XYLO do?
Xylo Technologies Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm developed a range of micro video cameras under micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD).
What is the stock price of XYLO TECHNOLOGIES LTD today?
The current stock price of XYLO is 5.07 USD.
Does XYLO stock pay dividends?
XYLO does not pay a dividend.
What is the ChartMill technical and fundamental rating of XYLO stock?
XYLO has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the valuation of XYLO TECHNOLOGIES LTD (XYLO) based on its PE ratio?
XYLO TECHNOLOGIES LTD (XYLO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.46).
What is the expected growth for XYLO stock?
The Revenue of XYLO TECHNOLOGIES LTD (XYLO) is expected to grow by 5.71% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.